Since its foundation, NHG Pharmaceuticals has been operating discreetly in the highly speculative medicinal cannabis market in Brazil. Structured by Fernando Cesar Mendes, formerly in charge of New Business Development for the world-famous Dutch company Green House Seed Co., financial entrepreneur Nathan Marcelo Moreira, and the American businessman Mark Neeleman, a co-founder of AZUL Brazilian Airlines, on its board of directors. Focused on the Brazilian law RDC 327/2019 (ANVISA), which paved the way for the import, manufacture, and distribution of cannabis-based products by pharmaceutical companies in Brazil, NHG formalized in the last 12 months exclusive product distribution contracts for API (active pharmaceutical ingredients) and finished pharmaceutical grade products with two of the largest EU-GMP certified facilities in Europe, located in Switzerland and the Czech Republic.

Canna Newswire, 03/07/2021 19:00:00

Open article: